Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors - 2018

Overview

In this one hour webinar, we will review and highlight the "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors".  We will discuss the updated guideline in terms of the evidence-based standards for clinical molecular testing of non-small cell lung cancers (NSCLC) that effectively guides targeted therapy and treatment.  We will identify where the guideline strengthens or reaffirms the 2013 recommendations for patients with lung adenocarcinoma, as well recommendations for testing for several new genes.  The latest evidence supporting these new testing technologies will be discussed, as will the anticipated impact on optimal patient care.

Date
Mar 29, 2018 -
Mar 29, 2018
Location

Online

After viewing this webinar attendees will be able to: 

  • Inform and educate clinicians as to updates and revisions of their Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors.
  • Review updated evidence and testing for new genes. 
  • Provide a multi-disciplinary perspective of the use and benefit of molecular testing.

Yasushi Yatabe, MD, PhD
Chief, Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.

For any inquiries, please contact meetings@iaslc.org.

After viewing this webinar attendees will be able to: 

  • Inform and educate clinicians as to updates and revisions of their Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors.
  • Review updated evidence and testing for new genes. 
  • Provide a multi-disciplinary perspective of the use and benefit of molecular testing.

Yasushi Yatabe, MD, PhD
Chief, Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.

For any inquiries, please contact meetings@iaslc.org.

Share